Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'c-Abl'

Search results for: 'c-Abl'

Items 21-30 of 93

Page
per page
  1. GW5074
    B1405 GW5074
    Summary: C-Raf inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥21.9 mg/mL
  2. GSK1070916
    A4127 GSK1070916
    Target: Aurora Kinases
    Summary: Aurora B/C inhibitor
      ≥25.4 mg/mL
  3. Golvatinib (E7050)
    B1439 Golvatinib (E7050)
    Target: VEGFR
    Summary: C-Met/VEGFR-2 inhibitor
  4. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: C-Met inhibitor,potent and ATP-competitive
  5. VX-680 (MK-0457,Tozasertib)
    A4111 VX-680 (MK-0457,Tozasertib)
    Target: Aurora Kinases
    Summary: Aurora kinase inhibitor
      ≥23.25 mg/mL
  6. KW 2449
    A4123 KW 2449
    Target: Aurora Kinases|FLT3|Bcr-Abl
    Summary: Multikinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥16.6 mg/mL
  7. PF-04217903 methanesulfonate
    A3712 PF-04217903 methanesulfonate
    Target: c-MET
    Summary: C-Met inhibitor,selective and ATP-competitive
      Soluble in DMSO
  8. (R)-Crizotinib
    A3020 (R)-Crizotinib
     2 Citation
    Target: c-MET
    Summary: C-MET/ALK inhibitor,potent and ATP-competitve
      insoluble in H2O; insoluble in EtOH; ≥7.51 mg/mL
  9. Radotinib(IY-5511)
    B5846 Radotinib(IY-5511)
    Target: PDGFR|Bcr-Abl
    Summary: Bcr-Abl tyrosine kinase inhibitor
      ≥13.73 mg/mL
  10. Tivantinib (ARQ 197)
    A8325 Tivantinib (ARQ 197)
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,non-ATP-competitive
      ≥18.47 mg/mL

Items 21-30 of 93

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 90item
  2. Probes & Dyes 1 item
Specificity
  1. Selective 63item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 6item
  2. Irreversible 2item
Target
  1. Proteasome 1 item
  2. CXCR 1 item
  3. Raf 10item
  4. Aurora Kinases 7item
  5. CSF-1R 1 item
  6. mTOR 1 item
  7. Bromodomains 1 item
  8. AP-1 1 item
  9. MMP 1 item
  10. FLT3 6item
  11. PLK 1 item
  12. Eph Receptors 2item
  13. VEGFR 19item
  14. PDGFR 16item
  15. c-Kit 11item
  16. RET 1 item
  17. Thymidylate Synthase 1 item
  18. Bcr-Abl 12item
  19. FGFR 6item
  20. Voltage-gated Sodium (NaV) Channels 1 item
  21. MET 5item
  22. Src 6item
  23. Trk Receptors 2item
  24. Microtubules/Tubulins 1 item
  25. EGFR 1 item
  26. FAK 1 item
  27. JAK 2item
  28. DNA-PK 1 item
  29. AMPK 1 item
  30. Cytochrome P450 (CYP450) 1 item
  31. c-MET 7item
  32. PKC 6item
  33. HCV Proteases 1 item
  34. Lyn 1 item
  35. PKA 1 item
  36. HIV-1 gp120 1 item
  37. Tie-2 2item
  38. Farnesyl Diphosphate Synthases 1 item
  39. Ron 1 item
  40. Synthases/Synthetases 1 item
  41. Histamine H1 Receptors 1 item
  42. P110 1 item
  43. Hck 1 item
  44. ZAP-70 1 item
  45. c-RET 1 item
  46. KDR 1 item
  47. c-Fms tyrosine kinase 1 item
  48. cysteine protease 1 item
  49. HCV polymerase 2item
  50. PC-PLC 2item
  51. sterol demethylase 1 item
  52. troponin 1 item
  53. glutamate release 1 item
  54. UCH 1 item
  55. HCV NS3-4A protease 1 item
  56. TRPC channel 1 item
Related Disease
  1. Acute Myeloid Leukemia 3item
  2. Adrenocortical Carcinoma 1 item
  3. Autoimmune Diseases 1 item
  4. Bladder Cancer 2item
  5. Bladder Carcinoma 1 item
  6. Breast Cancer 9item
  7. Cancer 58item
  8. Cholangiocarcinoma 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 7item
  11. Colon Carcinoma 2item
  12. Colorectal Cancer 7item
  13. Fungi 1 item
  14. Glioblastoma 4item
  15. Glioma 1 item
  16. HCV 2item
  17. Heart Failure 1 item
  18. Hepatitis C 2item
  19. Hepatocellular Carcinoma 1 item
  20. HIV 1 item
  21. Leukemia 4item
  22. Liver Cancer 1 item
  23. Lung Cancer 7item
  24. Lung Carcinoma 2item
  25. Lymphoma 2item
  26. Melanoma 6item
  27. Multiple Myeloma 2item
  28. Non-small Cell Lung Cancer 2item
  29. Ovarian Cancer 3item
  30. Pancreatic Cancer 7item
  31. Prostate Cancer 3item
  32. Renal Cancer 1 item
  33. Renal Cell Carcinoma 4item
  34. Rheumatoid Arthritis 1 item
  35. Thyroid Cancer 4item